Chinook Therapeutics, INC.
SEC CIK 1435049 · KDNY · last insider filing 2023-08-11
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Dobmeier Eric | Director · President, CEO | filed 2020 - 2023 |
| Griffin Michelle Renee | Director | filed 2020 - 2023 |
| Akkaraju Srinivas | Director | filed 2020 - 2023 |
| Greenman William Mariner | Director | filed 2015 - 2023 |
| Azelby Robert | Director | filed 2023 - 2023 |
| Jerel Davis | Director | filed 2020 - 2023 |
| Thomas Dolca | Director | filed 2020 - 2023 |
| Krishnan Mahesh | Director | filed 2022 - 2023 |
| Haghighat Ross | Director | filed 2015 - 2023 |
| Isaacs Stephen T | Director · President and CEO | filed 2015 - 2020 |
| Sherwin Stephen A | Director | filed 2015 - 2020 |
| Karbe Frank | Director | filed 2019 - 2020 |
| Mack David Henry | Director | filed 2019 - 2020 |
| Obrien Stephanie Monaghan | Director | filed 2015 - 2020 |
| Mccormick Frank | Director | filed 2015 - 2018 |
| Chan Gerald | Director | filed 2015 - 2018 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Bjerkholt Eric | Chief Financial Officer | filed 2020 - 2023 |
| Oxtoby Andrew | Chief Commercial Officer | filed 2023 - 2023 |
| King Andrew James | Head of Renal Discovery | filed 2020 - 2023 |
| Frohlich Tom | Chief Operating Officer | filed 2020 - 2023 |
| Glicklich Alan | Chief Medical Officer | filed 2020 - 2022 |
| Templeman Blaine | See Remarks | filed 2015 - 2020 |
| Ferber Celeste | SVP, GC and Secretary | filed 2019 - 2020 |
| Nuyten Dimitry SA | Chief Medical Officer | filed 2019 - 2020 |
| Kachioff William G | See Remarks | filed 2020 - 2020 |
| van Elsas Andrea | Chief Scientific Officer | filed 2017 - 2020 |
| Welch James H | See Remarks | filed 2019 - 2019 |
| Lew Jennifer | Sr. Vice President of Finance | filed 2015 - 2019 |
| Hoth Daniel Floyd JR | Interim Chief Medical Officer | filed 2018 - 2018 |
| Sacks Natalie | Chief Medical Officer | filed 2016 - 2018 |
| Schafer Gregory W | Chief Operating Officer | filed 2015 - 2018 |
| Brockstedt Dirk G. | Sr. VP of Research and Dev. | filed 2015 - 2018 |
| Dubensky Thomas W. | Chief Scientific Officer | filed 2015 - 2017 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.